Biofrontera AG (ETR:B8FK)
2.770
0.00 (0.00%)
Nov 16, 2026, 9:02 AM CET
Biofrontera AG Market Cap
Biofrontera AG has a market cap or net worth of €16.83 million as of November 13, 2026. It is the 37,283rd most valuable company in the world and the 494th biggest in Germany. Its market cap has increased by 3.75% in one year.
Market Cap
16.83M
Enterprise Value
11.36M
Revenue
15.97M
Global Rank
Country Rank
#494 Germany
PE Ratio
3.21
ChartMarket Cap Chart
Since October 31, 2006, Biofrontera AG's market cap has decreased from 38.05M to 16.83M, a decrease of -55.76%. That is a compound annual growth rate of -3.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 16, 2026 | 16.83M | 13.52% |
| Dec 30, 2025 | 14.83M | 13.49% |
| Dec 30, 2024 | 13.07M | -48.94% |
| Dec 29, 2023 | 25.59M | -73.70% |
| Dec 30, 2022 | 97.31M | 15.92% |
| Dec 30, 2021 | 83.94M | -42.36% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 65.04B |
| Bayer Aktiengesellschaft | 55.53B |
| Siemens Healthineers AG | 48.92B |
| Fresenius SE & Co. KGaA | 30.20B |
| Pentixapharm Holding AG | 45.35M |
| FamiCord AG | 42.71M |
| MeVis Medical Solutions AG | 36.40M |
| aap Implantate AG | 19.33M |